0 results available. Select is focused ,type to refine list, press Down to open the menu,
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes in the United States and internationally. The ...
The following section summarizes insights on Embecta Corp's Price / Fwd Sales:
We've identified the following companies as similar to Embecta Corp because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Price / Fwd Sales in the valuation category include:
Indicates the multiple of forward sales that stock investors are willing to pay for one share of the firm.
Forward Price / Sales also known as price-to-sales, or P/S ratio is a financial ratio that compares a company’s market capitalization to the amount of revenue the company is expected to earn in the next 12 months.
Price / Fwd Sales = Market Cap / Projected Revenue
Equivalently, it can also be calculated by dividing the per-share stock price by the per-share projected revenue.
The chart above depicts the distribution of price / fwd sales for companies operating in the Healthcare sector in the Developed economic region. Over 1,930 companies were considered in this analysis, and 1,856 had meaningful values. The average price / fwd sales of companies in the sector is 10.6x with a standard deviation of 26.3x.
Embecta Corp's Price / Fwd Sales of 0.7x ranks in the 23.0% percentile for the sector. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 1,934 |
| Included Constituents | 1,856 |
| Min | 0.0x |
| Max | 205.1x |
| Median | 2.1x |
| Mean | 10.6x |
| Standard Deviation | 26.3x |
You can find companies with similar price / fwd sales using this stock screener.